Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma-Reference-Cited by-同舟云学术

Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma

Published:2010-11-02 Issue:2 Volume:92 Page:87-96
ISSN:0959-9673
Container-title:International Journal of Experimental Pathology
language:en
Short-container-title:

Author:

Khoury Thaer,Chandrasekhar Rameela,Wilding Gregory,Tan Dongfeng,Cheney Richard T.

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2613.2010.00745.x/fullpdf

Reference35 articles.

1. Genomic instability, DNA alteration, and tumor eosinophilic expression head and neck squamous cell carcinoma;Alrawi;Cancer Genomics Proteomics,2005

2. Analysis of cell cycle regulator proteins in encapsulated thymomas;Baldi;Clin. Cancer Res.,2005

3. CD117 in soft tissue sarcomas;Barisella;Am. J. Clin. Pathol.,2002

4. Carcinomas of the cervix with intense stromal eosinophilia;Bostrom;Cancer,1981

5. The MIC2 antibody 013. Practical application assay for the study of thymic epithelial tumors;Chan;Am. J. Surg. Pathol.,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas;Cancers;2023-12-29

2. Recent developments in the pathology of primary pulmonary salivary gland‐type tumours;Histopathology;2023-09-11

3. EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma;Cancers;2023-04-13

4. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma;Thoracic Cancer;2023-03-16

5. CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets;Frontiers in Oncology;2022-01-25